Celgene Corp (NASDAQ:CELG)

99.37
Delayed Data
As of Sep 20
 +0.42 / +0.42%
Today’s Change
58.59
Today|||52-Week Range
99.66
+55.05%
Year-to-Date

Today’s Trading

Previous close98.95
Today’s open98.65
Day’s range98.50 - 99.66
Volume5,387,529
Average volume (3 months)3,978,476
Market cap$70.0B
Data as of 3:59pm ET, 09/20/2019

Growth & Valuation

Earnings growth (last year)+49.83%
Earnings growth (this year)+22.13%
Earnings growth (next 5 years)+20.50%
Revenue growth (last year)+19.26%
P/E ratio13.6
Price/Sales3.08
Price/Book11.22

Competitors

 Today’s
change
Today’s
% change
ZTSZoetis Inc+1.35+1.09%
BMYBristol-Myers Squibb+0.50+1.00%
----
AGNAllergan+0.74+0.45%
Data as of 6:30pm ET, 09/20/2019

Financials

Next reporting dateOctober 28, 2019
EPS forecast (this quarter)$2.69
Annual revenue (last year)$15.3B
Annual profit (last year)$4.0B
Net profit margin26.46%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman, President, CEO &
COO
Mark J. Alles
CFO, Principal Accounting Officer &
Executive VP
David V. Elkins
Corporate headquarters
Summit, New Jersey

Forecasts